John L. Higgins
2016
In 2016, John L. Higgins earned a total compensation of $5.4M as Chief Executive Officer at Ligand Pharmaceuticals, a 18% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $387,421 |
|---|---|
| Option Awards | $2,393,068 |
| Salary | $573,958 |
| Stock Awards | $1,992,215 |
| Other | $5,978 |
| Total | $5,352,640 |
Higgins received $2.4M in option awards, accounting for 45% of the total pay in 2016.
Higgins also received $387.4K in non-equity incentive plan, $574K in salary, $2M in stock awards and $6K in other compensation.
Rankings
In 2016, John L. Higgins' compensation ranked 1,449th out of 14,075 executives tracked by ExecPay. In other words, Higgins earned more than 89.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,449 out of 14,075 | 90th |
Division Manufacturing | 490 out of 5,489 | 91st |
Major group Chemicals And Allied Products | 136 out of 1,895 | 93rd |
Industry group Drugs | 92 out of 1,538 | 94th |
Industry Pharmaceutical Preparations | 73 out of 1,176 | 94th |
Source: SEC filing on April 14, 2017.
Higgins' colleagues
We found three more compensation records of executives who worked with John L. Higgins at Ligand Pharmaceuticals in 2016.